Olive oil shows an association with lower dementia-related mortality in a large observational study, while MCT oil produces metabolic changes but lacks evidence to prevent or treat dementia. The two oils rest on different types of evidence: olive oil comes from a 28-year follow-up of over 92,000 health professionals, whereas MCT oil's benefits remain inconsistent across controlled trials. Neither has been proven to prevent dementia onset through randomized testing.
The comparison hinges on study design. A Harvard-led study found that consuming more than 7 grams of olive oil daily (roughly half a tablespoon) was linked to a 28% lower risk of dementia-related death, but observational studies cannot prove oil caused the benefit—people who eat olive oil may differ in unmeasured ways. MCT oil, by contrast, has been tested in controlled trials and shows no clear ability to prevent dementia, though it does raise blood ketone levels.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the olive oil study found and what it missed
- MCT oil's metabolic promise and cognitive gap
- Why randomized trials matter more than observation
- Safety: Which oil is actually safer to use?
- What to do if you're considering either oil
- Frequently Asked Questions
What the olive oil study found and what it missed
The 2024 Harvard research tracked nearly 92,400 U.S. health professionals over 28 years and found a notable difference: those consuming the most olive oil had a 28% lower mortality risk from dementia compared to those who rarely or never consumed it. The effect held even when total diet quality was poor, suggesting olive oil's protection might operate independently of broader nutritional patterns.
However, this is observational evidence, not proof of cause-and-effect. Participants who eat olive oil regularly likely differ from non-consumers in education, income, healthcare access, and health behaviors—factors the study cannot fully measure. The researchers explicitly flagged that their sample was mostly White health professionals with at least two years of post-secondary education, limiting how well the findings apply to other racial, ethnic, and socioeconomic groups. To know whether olive oil itself prevents dementia deaths, researchers would need to randomly assign people to consume it versus a placebo—a study that has not yet been done at scale.
MCT oil's metabolic promise and cognitive gap
MCT (medium-chain triglyceride) oil is promoted as a dementia preventive because it metabolizes into ketones, which the brain can use for energy. A 2024 systematic review of 21 studies confirmed that MCT supplementation reliably increases blood ketones and brain metabolic rates, supporting the biological plausibility of the idea. Yet the same review found that actual cognitive improvements were "occasional or domain-specific"—meaning benefits appeared in some studies but not others, and only in narrow measures of thinking.
The critical gap: no studies have found that MCTs prevent dementia onset. Benefits, if they exist, appear limited to people already diagnosed with Alzheimer's disease or mild cognitive impairment. Researchers concluded that current evidence is insufficient to recommend MCT oil as a comparable symptomatic treatment option for dementia. For someone without cognitive impairment, MCT oil has no proven preventive value.
Why randomized trials matter more than observation
The evidence hierarchy matters when choosing what to trust. Observational studies like the olive oil research can identify patterns but cannot rule out confounding—unmeasured differences between groups that might explain the result. Randomized controlled trials randomly assign participants to treatment or placebo, eliminating most confounding. The olive oil literature includes only five randomized trials (involving 747 total participants) testing whether extra-virgin olive oil improves cognition in older adults.
These trials did show modest improvements in global cognitive scores, but they were small and heterogeneous—hard to combine into a clear recommendation. MCT oil has more RCT data (13 randomized trials in the 2024 review), yet this larger controlled evidence actually shows *less* benefit than olive oil's observational finding. This suggests that MCT's theoretical promise (raising ketones) does not consistently translate into measurable cognitive gains. Observation can suggest a connection worth testing; randomization tests whether the connection is real.
Safety: Which oil is actually safer to use?
Olive oil is safe for nearly all adults when consumed as food. The Harvard study tracked consumption over decades with no serious adverse events mentioned, and olive oil is a standard culinary and medical ingredient. MCT oil is also safe in healthy adults, but with an important caveat: gastrointestinal side effects—bloating, cramping, diarrhea—are common and frequent. This tolerability problem matters.
If someone cannot comfortably take MCT oil regularly without digestive distress, they will not stick with it long enough to see any benefit. In the clinical trials, GI complaints likely contributed to poor adherence. Olive oil has no such barrier—most people tolerate it well as a food. For someone with existing dementia, MCT oil's GI effects might be especially problematic, since older adults with cognitive decline may have difficulty reporting discomfort or managing dietary changes. Olive oil avoids this risk entirely.
What to do if you're considering either oil
If you are interested in olive oil for brain health, there is a reasonable rationale: the observational evidence is large and consistent, the safety profile is excellent, and it is already part of Mediterranean and MIND diets with some supporting research. A modest increase in olive oil consumption (roughly half a tablespoon daily) is unlikely to harm and may have other cardiovascular benefits. MCT oil is harder to justify unless you have a diagnosis of mild cognitive impairment or early Alzheimer's disease *and* tolerate it well.
In that specific case, it might be worth discussing with your doctor as a potential adjunct to standard treatment, though expectations should be modest. For prevention or general brain health in cognitively intact people, evidence does not support it. Neither oil should replace standard dementia prevention measures: regular physical activity, cognitive engagement, sleep, blood pressure and cholesterol management, and treatment of depression and hearing loss. These have stronger evidence and are known to reduce dementia risk.
Frequently Asked Questions
If olive oil works in the Harvard study, why can't I just start eating more of it?
You can, and the risk is minimal. The study found an association, not proof of cause-and-effect. People who eat olive oil may be healthier for other unmeasured reasons. Randomized trials would confirm whether olive oil itself is responsible, but such trials have not been done at large scale.
Should I take MCT oil if I have mild cognitive impairment?
Discuss it with your doctor. MCT does raise brain ketones reliably, and some people with cognitive impairment show modest improvement. However, it commonly causes digestive distress, and evidence of benefit is inconsistent. It is not a substitute for other proven treatments.
Can I use both olive oil and MCT oil together?
Yes, there is no interaction concern. However, MCT oil's GI effects may limit how much you can tolerate, and starting with one oil at a time will help you identify which one suits you.
How much olive oil do the benefits begin at?
The Harvard study found a 28% reduction in dementia mortality at intakes above 7 grams daily (roughly half a tablespoon). Lower amounts were not studied in detail, so the threshold for benefit is unclear.
